WINNIPEG, MB – Health Canada is advising people that one lot of the Ventolin Diskus inhalers is being recalled.
GlaxoSmithKline, the makers of Ventolin Diskus inhalers is voluntarily recalling products from lot 786G because they may not deliver the intended dose. People who do not receive the intended dose may not be aware that the dose was not delivered.
Ventolin Diskus is a prescription drug used in adults and children 4 years or older to relieve and prevent bronchospasm due to asthma, chronic bronchitis and other chronic lung disorders. Bronchospasm is a sudden worsening of shortness of breath and wheezing. Ventolin Diskus is also used to prevent exercise-induced bronchospasm.
The concern is that if individuals do not receive the proper dose, their symptoms (cough, wheeze, breathlessness or tight chest) may get worse over time and they can suffer serious health consequences, including a potentially life-threatening asthma attack.
The specific product recalled is Ventolin Diskus (200 mcg salbutamol per blister (60 Dose) (DIN 02243115)) Lot 786G, Expiry 05 2019.
In the picture below you can see where to find the lot number.
David Marshal, Manitoba Post
Photo fromhealthycanadians.ca